Segment Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Segment Wealth Management's BMY Position: Q2 2022 in Review
Segment Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 4,173 shares — an estimated $305K sold.
Segment Wealth Management first reported a position in BMY in Q2 2013 and held it in 26 quarters. The position peaked at $669K in Q3 2017. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Segment Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
- Segment Wealth Management sold 4,173 Bristol-Myers Squibb shares in Q2 2022, an estimated $305K.
- Segment Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 26 quarters.
- Segment Wealth Management's Bristol-Myers Squibb position peaked at $669K in Q3 2017.
- 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Segment Wealth Management's 13F filing for Q2 2022, filed 20 Jul 2022.